Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Takeshi Takamoto is a leading hepatobiliary and pancreatic surgeon whose work is reshaping the surgical management of complex abdominal cancers. His primary research focuses on hepatocellular carcinoma (HCC) and the refinement of robotic pancreaticoduodenectomy (RPD). Dr. Takamoto’s major contributions include a landmark 2025 review on multidisciplinary strategies for HCC, which addresses the 800,000 new global cases annually and has already garnered 5 citations. In the realm of pancreatic surgery, he has pioneered technical innovations to reduce life-threatening complications. His work on pancreatojejunostomy and gastrojejunostomy during RPD (4 citations) offers critical insights into stent techniques for preventing pancreatic fistula and delayed gastric emptying. Most notably, Dr. Takamoto developed the “pancreatic head clockwise devascularization” technique, a novel method to minimize intraoperative bleeding during RPD by standardizing the order of vessel division. This achievement, detailed in a 2025 paper (2 citations), represents a significant step toward safer, more reproducible robotic surgery. Through these contributions, Dr. Takamoto is advancing the frontiers of minimally invasive surgery, directly improving outcomes for patients with some of the most challenging malignancies.